Lushang Freda Pharmaceutical Co.,Ltd.

¥5.33As of Sun 8 Nov 2026, 12:00 UTC
SSE:600223Real Estate
Country China
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 1.07%
ROE 4.08%
Real Estate (Development)
Beta (5Y) 0.85
PE TTM 35.32
TSR TTM (30.77%)
Mkt cap ¥5.418B
ROIC 6.24%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.30
18.24%
(70.97%)
Buy 2|2|7|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.08
0.08
0.08
15.69%
4.64%
14.03%
17.66%
Revenue¥M
301.7
318.5
327.1
330.5
6.08%
6.84%
5.49%
9.34%
Peers (US$812.2M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.958
(0.021)
(0.019)
EBIT/Intx
0.264
0.314
0.321
Own earn%
52.25
321.20
229.98
Sh yield%
28.64
19.07
20.37
Owners
Insiders/Inst%
2.78
52.52
Short interest%
2.94
SBC / revenue%
1.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
11–15
$1 testx
−0.1
Incr. ROIC%
52